NCT01751516View on ClinicalTrials.gov

PET/MRI as a Predictor of Response to Pre-op Chemoradiation in Resectable Rectal Cancer: a Pilot Study

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

August 31, 2014

Study Completion Date

March 4, 2018

Conditions
Rectal Carcinoma
Trial Locations (1)

27599

University of North Carolina-Chapel Hill, Chapel Hill

All Listed Sponsors
lead

UNC Lineberger Comprehensive Cancer Center

OTHER

NCT01751516 - PET/MRI as a Predictor of Response to Pre-op Chemoradiation in Resectable Rectal Cancer: a Pilot Study | Biotech Hunter | Biotech Hunter